Back to results
UnknownEARLY_Phase 1

SRC Inhibition as a Potential Target for Parkinson's Disease Psychosis

NCT03661125

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Mitul Mehta

London, Camberwell, United Kingdom

View on ClinicalTrials.gov
SRC Inhibition as a Potential Target for Parkinson's Disease Psychosis — TrialFind